142 related articles for article (PubMed ID: 9788258)
1. Coexpression of HGF and c-Met/HGF receptor in human bone and soft tissue tumors.
Fukuda T; Ichimura E; Shinozaki T; Sano T; Kashiwabara K; Oyama T; Nakajima T; Nakamura T
Pathol Int; 1998 Oct; 48(10):757-62. PubMed ID: 9788258
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.
Wallenius V; Hisaoka M; Helou K; Levan G; Mandahl N; Meis-Kindblom JM; Kindblom LG; Jansson JO
Am J Pathol; 2000 Mar; 156(3):821-9. PubMed ID: 10702398
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of hepatocyte growth factor and c-Met proto-oncogene product in synovial sarcoma.
Motoi T; Ishida T; Kuroda M; Horiuchi H; Oka T; Matsumoto K; Nakamura T; Machinami R
Pathol Int; 1998 Oct; 48(10):769-75. PubMed ID: 9788260
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of hepatocyte growth factor and its receptor c-Met correlates with high MIB-1 proliferative index in malignant fibrous histiocytoma.
Yamamoto T; Marui T; Akisue T; Nakatani T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Kurosaka M
Pathol Res Pract; 2004; 200(5):397-402. PubMed ID: 15239348
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-Met receptor and hepatocyte growth factor/scatter factor in synovial sarcoma and epithelioid sarcoma.
Kuhnen C; Tolnay E; Steinau HU; Voss B; Müller KM
Virchows Arch; 1998 Apr; 432(4):337-42. PubMed ID: 9565343
[TBL] [Abstract][Full Text] [Related]
6. The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study.
Lahat G; Zhang P; Zhu QS; Torres K; Ghadimi M; Smith KD; Wang WL; Lazar AJ; Lev D
Histopathology; 2011 Sep; 59(3):556-61. PubMed ID: 22034893
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
8. Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.
Scotlandi K; Baldini N; Oliviero M; Di Renzo MF; Martano M; Serra M; Manara MC; Comoglio PM; Ferracini R
Am J Pathol; 1996 Oct; 149(4):1209-19. PubMed ID: 8863670
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
10. Expression of osteopontin and HGF/met in adult soft tissue tumors.
Bramwell VH; Tuck AB; Wilson SM; Stitt LW; Cherian AK; Rorke SC; Al-Katib W; Postenka CO; Chambers AF
Cancer Biol Ther; 2005 Dec; 4(12):1336-41. PubMed ID: 16258259
[TBL] [Abstract][Full Text] [Related]
11. Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathway.
Van Mater D; Añó L; Blum JM; Webster MT; Huang W; Williams N; Ma Y; Cardona DM; Fan CM; Kirsch DG
Cancer Res; 2015 Feb; 75(3):605-14. PubMed ID: 25503558
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation.
Sato H; Hasegawa T; Abe Y; Sakai H; Hirohashi S
Hum Pathol; 1999 Nov; 30(11):1344-9. PubMed ID: 10571515
[TBL] [Abstract][Full Text] [Related]
13. Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.
Ueda T; Araki N; Mano M; Myoui A; Joyama S; Ishiguro S; Yamamura H; Takahashi K; Kudawara I; Yoshikawa H
J Clin Pathol; 2002 Nov; 55(11):853-8. PubMed ID: 12401825
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma.
Oda Y; Sakamoto A; Saito T; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2000 Feb; 31(2):185-92. PubMed ID: 10685632
[TBL] [Abstract][Full Text] [Related]
15. Expression of bone morphogenetic protein and its receptors in osteosarcoma and malignant fibrous histiocytoma.
Mehdi R; Shimizu T; Yoshimura Y; Gomyo H; Takaoka K
Jpn J Clin Oncol; 2000 Jun; 30(6):272-5. PubMed ID: 10939432
[TBL] [Abstract][Full Text] [Related]
16. FU-3 monoclonal antibody: a specific marker for malignant fibrous histiocytoma? An analysis of 32 malignant soft tissue and bone sarcomas.
Perez-Bacete MJ; Llombart-Bosch A
Virchows Arch; 1994; 424(3):243-7. PubMed ID: 8186889
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure.
Liu Y; Tolbert EM; Lin L; Thursby MA; Sun AM; Nakamura T; Dworkin LD
Kidney Int; 1999 Feb; 55(2):442-53. PubMed ID: 9987069
[TBL] [Abstract][Full Text] [Related]
18. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
Ferracini R; Di Renzo MF; Scotlandi K; Baldini N; Olivero M; Lollini P; Cremona O; Campanacci M; Comoglio PM
Oncogene; 1995 Feb; 10(4):739-49. PubMed ID: 7862451
[TBL] [Abstract][Full Text] [Related]
19. [An analysis of autopsy cases of malignant soft tissue and bone tumors].
Enjoji M; Hashimoto H; Yamamoto I; Daimaru Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1931-6. PubMed ID: 2543328
[TBL] [Abstract][Full Text] [Related]
20. [Histogenesis of malignant fibrous histiocytoma and giant-cell tumor of bone].
Petrovichev NN; Chobonian NS; Annamukhamed AA; Khodzhamuratov DKh
Arkh Patol; 1985; 47(7):11-6. PubMed ID: 2996470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
